Fritz P - Search Results

1

Microsomal epoxide hydrolase expression as a predictor of tamoxifen response in primary breast cancer: a retrospective exploratory study with long-term follow-up.

Fritz P, Mürdter TE, Eichelbaum M, Siegle I, Weissert M, Zanger UM. Fritz P, et al. J Clin Oncol. 2001 Jan 1;19(1):3-9. doi: 10.1200/JCO.2001.19.1.3. J Clin Oncol. 2001. PMID: 11134189

2

Breast cancer treatment outcome with adjuvant tamoxifen relative to patient CYP2D6 and CYP2C19 genotypes.

Schroth W, Antoniadou L, Fritz P, Schwab M, Muerdter T, Zanger UM, Simon W, Eichelbaum M, Brauch H. Schroth W, et al. Among authors: fritz p. J Clin Oncol. 2007 Nov 20;25(33):5187-93. doi: 10.1200/JCO.2007.12.2705. J Clin Oncol. 2007. PMID: 18024866

3

Immunohistochemical assessment of human microsomal epoxide hydrolase in primary and secondary liver neoplasm: a quantitative approach.

Fritz P, Behrle E, Zanger UM, Mürdter T, Schwarzmann P, Kroemer HK. Fritz P, et al. Xenobiotica. 1996 Jan;26(1):107-16. doi: 10.3109/00498259609046692. Xenobiotica. 1996. PMID: 8851825

4

Immunohistochemical detection of microsomal epoxide hydrolase in human synovial tissue.

Backman JT, Siegle I, Zanger UM, Fritz P. Backman JT, et al. Among authors: fritz p. Histochem J. 1999 Oct;31(10):645-9. doi: 10.1023/a:1003843502831. Histochem J. 1999. PMID: 10576413

5

Distribution of microsomal epoxide hydrolase in humans: an immunohistochemical study in normal tissues, and benign and malignant tumours.

Coller JK, Fritz P, Zanger UM, Siegle I, Eichelbaum M, Kroemer HK, Mürdter TE. Coller JK, et al. Among authors: fritz p. Histochem J. 2001 Jun;33(6):329-36. doi: 10.1023/a:1012414806166. Histochem J. 2001. PMID: 11758809

6

Impact of mistletoe lectin binding in breast cancer.

Fritz P, Dippon J, Kierschke T, Siegle I, Möhring A, Moisa A, Mürdter TE. Fritz P, et al. Anticancer Res. 2004 Mar-Apr;24(2C):1187-92. Anticancer Res. 2004. PMID: 15154645 Free article.

7

Short term culture of breast cancer tissues to study the activity of the anticancer drug taxol in an intact tumor environment.

van der Kuip H, Mürdter TE, Sonnenberg M, McClellan M, Gutzeit S, Gerteis A, Simon W, Fritz P, Aulitzky WE. van der Kuip H, et al. Among authors: fritz p. BMC Cancer. 2006 Apr 7;6:86. doi: 10.1186/1471-2407-6-86. BMC Cancer. 2006. PMID: 16603054 Free PMC article.

8

A polymorphism in the TC21 promoter associates with an unfavorable tamoxifen treatment outcome in breast cancer.

Rokavec M, Schroth W, Amaral SM, Fritz P, Antoniadou L, Glavac D, Simon W, Schwab M, Eichelbaum M, Brauch H. Rokavec M, et al. Among authors: fritz p. Cancer Res. 2008 Dec 1;68(23):9799-808. doi: 10.1158/0008-5472.CAN-08-0247. Cancer Res. 2008. PMID: 19047159

9

TKTL-1 expression in lung cancer.

Fritz P, Coy JF, Mürdter TE, Ott G, Alscher MD, Friedel G. Fritz P, et al. Pathol Res Pract. 2012 Apr 15;208(4):203-9. doi: 10.1016/j.prp.2012.01.007. Epub 2012 Mar 24. Pathol Res Pract. 2012. PMID: 22445516

10

Ligands for Viscum album agglutinin and galectin-1 in human lung cancer: is there any prognostic relevance?

Fritz P, Seizer-Schmidt R, Mürdter TE, Kroemer HK, Aulitzky W, André S, Gabius HJ, Friedel G, Toomes H, Siegle I. Fritz P, et al. Acta Histochem. 1999 Jul;101(3):239-53. doi: 10.1016/s0065-1281(99)80025-7. Acta Histochem. 1999. PMID: 10443287

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

403 results

Search Page

Filters